These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


607 related items for PubMed ID: 17611054

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison.
    Yang CH, Huang KS, Grumezescu AM, Wang CY, Tzeng SC, Chen SY, Lin YH, Lin YS.
    Electrophoresis; 2014 Feb; 35(2-3):316-22. PubMed ID: 23857679
    [Abstract] [Full Text] [Related]

  • 23. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.
    Walter E, Moelling K, Pavlovic J, Merkle HP.
    J Control Release; 1999 Sep 20; 61(3):361-74. PubMed ID: 10477808
    [Abstract] [Full Text] [Related]

  • 24. Design of amine-modified graft polyesters for effective gene delivery using DNA-loaded nanoparticles.
    Oster CG, Wittmar M, Unger F, Barbu-Tudoran L, Schaper AK, Kissel T.
    Pharm Res; 2004 Jun 20; 21(6):927-31. PubMed ID: 15212155
    [Abstract] [Full Text] [Related]

  • 25. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
    Oster CG, Kim N, Grode L, Barbu-Tudoran L, Schaper AK, Kaufmann SH, Kissel T.
    J Control Release; 2005 May 18; 104(2):359-77. PubMed ID: 15907586
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics.
    Jeon HJ, Jeong YI, Jang MK, Park YH, Nah JW.
    Int J Pharm; 2000 Oct 10; 207(1-2):99-108. PubMed ID: 11036235
    [Abstract] [Full Text] [Related]

  • 28. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
    Chen J, Tian B, Yin X, Zhang Y, Hu D, Hu Z, Liu M, Pan Y, Zhao J, Li H, Hou C, Wang J, Zhang Y.
    J Biotechnol; 2007 Jun 15; 130(2):107-13. PubMed ID: 17467097
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
    Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z.
    Pharm Res; 2010 Jul 15; 27(7):1285-95. PubMed ID: 20309616
    [Abstract] [Full Text] [Related]

  • 31. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S, Tros de Ilarduya C.
    Eur J Pharm Biopharm; 2006 Jun 15; 63(2):188-97. PubMed ID: 16697172
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
    Prior S, Gamazo C, Irache JM, Merkle HP, Gander B.
    Int J Pharm; 2000 Feb 25; 196(1):115-25. PubMed ID: 10675713
    [Abstract] [Full Text] [Related]

  • 39. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H, Arica-Yegin B, Vural I, Goracinova K, Caliş S.
    Drug Dev Ind Pharm; 2014 Apr 25; 40(4):560-7. PubMed ID: 23596973
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 31.